Terms: = Leukemia AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Treatment
81 results:
1. Inhibition of nrf2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid leukemia.
Jebanesan DZP; Illangeswaran RSS; Rajamani BM; Vidhyadharan RT; Das S; Bijukumar NK; Balakrishnan B; Mathews V; Velayudhan SR; Balasubramanian P
Ann Hematol; 2024 Jun; 103(6):1919-1929. PubMed ID: 38630133
[TBL] [Abstract] [Full Text] [Related]
2. Roles of Glutathione and AP-1 in the Enhancement of Vitamin D-Induced Differentiation by Activators of the nrf2 Signaling Pathway in Acute Myeloid leukemia Cells.
Jramne-Saleem Y; Danilenko M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396960
[TBL] [Abstract] [Full Text] [Related]
3. Activation of APE1 modulates nrf2 protected against acute liver injury by inhibit hepatocyte ferroptosis and promote hepatocyte autophagy.
Diao J; Fan H; Zhang J; Fu X; Liao R; Zhao P; Huang W; Huang S; Liao H; Yu J; Pan D; Wang M; Xiao W; Wen X
Int Immunopharmacol; 2024 Feb; 128():111529. PubMed ID: 38244516
[TBL] [Abstract] [Full Text] [Related]
4. Venetoclax and Hypomethylating Agent Combination in Myeloid Malignancies: Mechanisms of Synergy and Challenges of Resistance.
Mishra R; Zokaei Nikoo M; Veeraballi S; Singh A
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203655
[TBL] [Abstract] [Full Text] [Related]
5. Ovatodiolide induces autophagy-mediated cell death through the p62-Keap1-nrf2 signaling pathway in chronic myeloid leukemia cells.
Xia Q; Xie J; Zhang J; Zhang L; Zhou Y; Zhu B; Wu Y; Yang Z; Li J
Chem Biol Interact; 2024 Jan; 387():110819. PubMed ID: 38000454
[TBL] [Abstract] [Full Text] [Related]
6. Targeting the NF-E2-related factor 2 pathway for overcoming leukemia.
Harifi-Mood MS; Daroudi M; Darroudi M; Naseri K; Samarghandian S; Farkhondeh T
Int J Biol Macromol; 2023 Dec; 253(Pt 8):127594. PubMed ID: 37890739
[TBL] [Abstract] [Full Text] [Related]
7. Anti-inflammatory effects of cold atmospheric plasma irradiation on the THP-1 human acute monocytic leukemia cell line.
Hirasawa I; Odagiri H; Park G; Sanghavi R; Oshita T; Togi A; Yoshikawa K; Mizutani K; Takeuchi Y; Kobayashi H; Katagiri S; Iwata T; Aoki A
PLoS One; 2023; 18(10):e0292267. PubMed ID: 37851686
[TBL] [Abstract] [Full Text] [Related]
8. Duality of Valproic Acid Effects on Inflammation, Oxidative Stress and Autophagy in Human Eosinophilic Cells.
Uzel G; Oylumlu E; Durmus L; Ciraci C
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686250
[TBL] [Abstract] [Full Text] [Related]
9. ATO Increases ROS Production and Apoptosis of Cells by Enhancing Calpain-Mediated Degradation of the Cancer Survival Protein TG2.
Jambrovics K; Póliska S; Scholtz B; Uray IP; Balajthy Z
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446117
[TBL] [Abstract] [Full Text] [Related]
10. Identification of nrf2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia.
Villa-Morales M; Pérez-Gómez L; Pérez-Gómez E; López-Nieva P; Fernández-Navarro P; Santos J
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373496
[TBL] [Abstract] [Full Text] [Related]
11. DNMT3A R882H mutation promotes acute leukemic cell survival by regulating glycolysis through the nrf2/NQO1 axis.
Chu X; Zhong L; Dan W; Wang X; Zhang Z; Liu Z; Lu Y; Shao X; Zhou Z; Chen S; Liu B
Cell Signal; 2023 May; 105():110626. PubMed ID: 36758683
[TBL] [Abstract] [Full Text] [Related]
12. Nuclear factor nrf2 promotes glycosidase OGG1 expression by activating the AKT pathway to enhance leukemia cell resistance to cytarabine.
Shang Q; Pan C; Zhang X; Yang T; Hu T; Zheng L; Cao S; Feng C; Hu X; Chai X; Wang J; Fang Q
J Biol Chem; 2023 Jan; 299(1):102798. PubMed ID: 36528059
[TBL] [Abstract] [Full Text] [Related]
13. Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies.
Wild SA; Cannell IG; Nicholls A; Kania K; Bressan D; ; Hannon GJ; Sawicka K
Elife; 2022 Dec; 11():. PubMed ID: 36525288
[TBL] [Abstract] [Full Text] [Related]
14. nrf2 affects hydroquinone-induces cell cycle arrest through the p16/pRb signaling pathway and antioxidant enzymes.
Chen L; Zhai L; Gao Y; Cui Z; Yu L; Zhu D; Tang H; Luo H
Ecotoxicol Environ Saf; 2023 Jan; 249():114389. PubMed ID: 36508791
[TBL] [Abstract] [Full Text] [Related]
15. Omics-based identification of an nrf2-related auranofin resistance signature in cancer: Insights into drug repurposing.
Falchetti M; Delgobo M; Zancanaro H; Almeida K; das Neves RN; Dos Santos B; Stefanes NM; Bishop A; Santos-Silva MC; Zanotto-Filho A
Comput Biol Med; 2023 Jan; 152():106347. PubMed ID: 36493734
[TBL] [Abstract] [Full Text] [Related]
16. All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-nrf2 complex.
Wang L; Zhang Q; Ye L; Ye X; Yang W; Zhang H; Zhou X; Ren Y; Ma L; Zhang X; Mei C; Xu G; Li K; Luo Y; Jiang L; Lin P; Zhu S; Lang W; Wang Y; Shen C; Han Y; Liu X; Yang H; Lu C; Sun J; Jin J; Tong H
Br J Cancer; 2023 Feb; 128(4):691-701. PubMed ID: 36482192
[TBL] [Abstract] [Full Text] [Related]
17. Triptolide promotes ferroptosis by suppressing nrf2 to overcome leukemia cell resistance to doxorubicin.
Wu X; Chen S; Huang K; Lin G
Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36453238
[TBL] [Abstract] [Full Text] [Related]
18. Anti-Leukemic Activity of Brassica-Derived Bioactive Compounds in HL-60 Myeloid leukemia Cells.
Núñez-Sánchez MÁ; Martínez-Sánchez MA; Verdejo-Sánchez M; García-Ibáñez P; Oliva Bolarín A; Ramos-Molina B; Moreno DA; Ruiz-Alcaraz AJ
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362202
[TBL] [Abstract] [Full Text] [Related]
19. DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating nrf2/NQO1 pathway.
Chu X; Zhong L; Dan W; Wang X; Zhang Z; Liu Z; Lu Y; Shao X; Zhou Z; Chen S; Liu B
Cell Commun Signal; 2022 Oct; 20(1):168. PubMed ID: 36303144
[TBL] [Abstract] [Full Text] [Related]
20. WASH regulates the oxidative stress nrf2/ARE pathway to inhibit proliferation and promote apoptosis of HeLa cells under the action of Jolkinolide B.
Hong Y; Liu J; Kong W; Li H; Cui Y; Liu Y; Deng Z; Ma D; Zhang K; Li J; Li M
PeerJ; 2022; 10():e13499. PubMed ID: 35855902
[TBL] [Abstract] [Full Text] [Related]
[Next]
